We found that the combination treatment MK-2206 plus CsA determined a marked decrease in the expression of Claspin, Mcl-1 and an increase in Bim isoforms in Jurkat T-ALL cells. This evidence concerns the gene BCL2L11 and acute lymphoblastic leukemia.